Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Director, Chairman & Chief Executive Off, 10% Owner · OSR Health, Inc. · OSRH
Grant or award — administrative, little informational value
$267K reported value · new position
Disclosed 15 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 34 | Kim YeiseokChief Operating Officer | Grant or award | A | $67K 293.4K sh | Nov 19, 2026 traded Oct 29, 2026 | |
| 22 | Bang GihyounChief Financial Officer | Grant or award | A | $100K 440.1K sh | Nov 19, 2026 traded Oct 29, 2026 | |
| 19 | Cho Joong MyungDirector | Grant or award | A | — 120.0K sh | Nov 19, 2026 traded Oct 29, 2026 | |
| 19 | Barberis AlcideDirector | Grant or award | A | — 120.0K sh | Nov 19, 2026 traded Oct 29, 2026 | |
| 19 | Mah Seng ChinDirector | Grant or award | A | — 120.0K sh | Nov 19, 2026 traded Oct 29, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $266,664
Hwang Kuk Hyoun filed this Form 4 reporting a grant or award of OSRH on Oct 29, 2026. It became public on Nov 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.